Via Email Only (jlubniewski@htgmolecular.com)HTG Molecular Diagnostics, Inc • February 25th, 2015 • Laboratory analytical instruments
Company FiledFebruary 25th, 2015 IndustryOn behalf of HTG Molecular Diagnostics, Inc. (the “Company”), I am pleased to offer you continued employment at the Company on the terms set forth in this letter agreement (this “Agreement”). Subject to your acceptance by signing below, this Agreement will become effective upon the date of the underwriting agreement between the Company and the underwriter(s) managing the initial public offering of the Company’s common stock, pursuant to which such common stock is priced for the initial public offering (the “Effective Date”). As of the Effective Date, this Agreement replaces and supersedes in its entirety the letter agreement between you and the Company dated March 30, 2011 (the “Prior Agreement”), as provided in Section 12 below.
Via Email Only (dgordon@htgmolecular.com)HTG Molecular Diagnostics, Inc • February 25th, 2015 • Laboratory analytical instruments • Arizona
Company FiledFebruary 25th, 2015 Industry JurisdictionOn behalf of HTG Molecular Diagnostics, Inc. (the “Company”), I am pleased to offer you continued employment at the Company on the terms set forth in this letter agreement (this “Agreement”). Subject to your acceptance by signing below, this Agreement will become effective upon the date of the underwriting agreement between the Company and the underwriter(s) managing the initial public offering of the Company’s common stock, pursuant to which such common stock is priced for the initial public offering (the “Effective Date”). As of the Effective Date, this Agreement replaces and supersedes in its entirety the letter agreement between you and the Company dated April 27, 2011(the “Prior Agreement”), as provided in Section 12 below.
Via Email Only (proche@htgmolecular.com)HTG Molecular Diagnostics, Inc • February 25th, 2015 • Laboratory analytical instruments
Company FiledFebruary 25th, 2015 IndustryOn behalf of HTG Molecular Diagnostics, Inc. (the “Company”), I am pleased to offer you continued employment at the Company on the terms set forth in this letter agreement (this “Agreement”). Subject to your acceptance by signing below, this Agreement will become effective upon the date of the underwriting agreement between the Company and the underwriter(s) managing the initial public offering of the Company’s common stock, pursuant to which such common stock is priced for the initial public offering (the “Effective Date”). As of the Effective Date, this Agreement replaces and supersedes in its entirety the letter agreement between you and the Company dated March 4, 2014(the “Prior Agreement”), as provided in Section 12 below.
August 31, 2013Celladon Corp • January 28th, 2014 • Biological products, (no disgnostic substances)
Company FiledJanuary 28th, 2014 IndustryOn behalf of Celladon Corporation (the “Company”), I am pleased to offer you continued employment at the Company on the terms set forth in this letter agreement (the “Agreement”). Subject to your acceptance by signing below, this Agreement will become effective upon the date of the underwriting agreement between the Company and the underwriter(s) managing the initial public offering of the Company’s common stock, pursuant to which such common stock is priced for the initial public offering (the “Effective Date”). As of the Effective Date, this Agreement replaces and supersedes in its entirety the letter agreement between you and the Company dated March 29, 2012 (the “Prior Agreement”), as provided in Section 12 below.
August 31, 2013Celladon Corp • October 11th, 2013 • Biological products, (no disgnostic substances)
Company FiledOctober 11th, 2013 IndustryOn behalf of Celladon Corporation (the “Company”), I am pleased to offer you continued employment at the Company on the terms set forth in this letter agreement (the “Agreement”). Subject to your acceptance by signing below, this Agreement will become effective upon the date of the underwriting agreement between the Company and the underwriter(s) managing the initial public offering of the Company’s common stock, pursuant to which such common stock is priced for the initial public offering (the “Effective Date”). As of the Effective Date, this Agreement replaces and supersedes in its entirety the letter agreement between you and the Company dated March 29, 2012 (the “Prior Agreement”), as provided in Section 12 below.